Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
US Army
Farmers Insurance
Deloitte
Moodys
McKesson

Generated: March 18, 2019

DrugPatentWatch Database Preview

Neurocrine Company Profile

« Back to Dashboard

What is the competitive landscape for NEUROCRINE, and what generic alternatives to NEUROCRINE drugs are available?

NEUROCRINE has one approved drug.

There are three US patents protecting NEUROCRINE drugs.

There are twenty-eight patent family members on NEUROCRINE drugs in seventeen countries.

Summary for Neurocrine
International Patents:28
US Patents:3
Tradenames:1
Ingredients:1
NDAs:1

Drugs and US Patents for Neurocrine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Neurocrine INGREZZA valbenazine tosylate CAPSULE;ORAL 209241-002 Oct 4, 2017 RX Yes No 8,039,627 ➤ Try a Free Trial Y Y ➤ Try a Free Trial
Neurocrine INGREZZA valbenazine tosylate CAPSULE;ORAL 209241-001 Apr 11, 2017 RX Yes Yes 8,039,627 ➤ Try a Free Trial Y Y ➤ Try a Free Trial
Neurocrine INGREZZA valbenazine tosylate CAPSULE;ORAL 209241-002 Oct 4, 2017 RX Yes No 8,357,697 ➤ Try a Free Trial ➤ Try a Free Trial
Neurocrine INGREZZA valbenazine tosylate CAPSULE;ORAL 209241-001 Apr 11, 2017 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial
Neurocrine INGREZZA valbenazine tosylate CAPSULE;ORAL 209241-002 Oct 4, 2017 RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial
Neurocrine INGREZZA valbenazine tosylate CAPSULE;ORAL 209241-002 Oct 4, 2017 RX Yes No 10,065,952 ➤ Try a Free Trial Y Y ➤ Try a Free Trial
Neurocrine INGREZZA valbenazine tosylate CAPSULE;ORAL 209241-001 Apr 11, 2017 RX Yes Yes 10,065,952 ➤ Try a Free Trial Y Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Neurocrine Drugs

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Moodys
US Department of Justice
US Army
Baxter
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.